Psilocybin PTSD Treatment: Where the Research Stands in 2026
Psilocybin PTSD treatment is still investigational. The strongest evidence so far is a single small open-label trial of 22 people, which showed meaningful symptom reductions but...
Psychedelics and Trauma: How These Medicines Work at the Neurological Level
Psychedelics appear to address trauma by temporarily increasing the brain’s capacity to change, opening a window in which fear-based memories become editable rather than fixed. The...
Complex PTSD Psychedelic Therapy: Why cPTSD Is Different from PTSD
Complex PTSD (cPTSD) differs from PTSD because it develops from prolonged, repeated trauma, and it adds lasting disturbances in emotional regulation, self-worth, and relationships on top...
MDMA for Childhood Trauma: What the Research Shows About Healing Early Wounds
No clinical trial has yet tested MDMA-assisted therapy specifically for childhood trauma as a standalone diagnosis, so the real answer is that direct evidence does not...
MDMA for Complex PTSD: Why Standard Treatments Fall Short
MDMA for complex PTSD has not been tested in a dedicated clinical trial, so no treatment can honestly claim proven results for this diagnosis. What we...
MDMA PTSD Therapy: Inside the Most Promising Psychedelic Research Ever Conducted
MDMA PTSD therapy produced the strongest results of any psychedelic research program to date. Across two Phase 3 trials, roughly seven in ten participants no longer...
Ketamine PTSD Treatment: What the Clinical Evidence Shows
Ketamine PTSD treatment has produced rapid symptom relief in small controlled trials, with some participants improving within hours rather than weeks. The evidence is promising but...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.